5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.95▲ | 1.98▼ | 1.98▼ | 2.07▼ | 1.78▲ |
MA10 | 1.96▲ | 1.98▼ | 2.02▼ | 1.95▲ | 1.78▲ |
MA20 | 1.97▼ | 2.03▼ | 2.05▼ | 1.82▲ | 1.76▲ |
MA50 | 1.98▼ | 2.04▼ | 2.02▼ | 1.75▲ | 1.92▲ |
MA100 | 2.03▼ | 1.99▼ | 1.89▲ | 1.75▲ | 2.26▼ |
MA200 | 2.05▼ | 1.86▲ | 1.80▲ | 1.91▲ | 3.08▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.007▼ | -0.017▼ | 0.027▲ | 0.034▲ |
RSI | 49.284▼ | 38.540▼ | 41.481▼ | 55.933▲ | 53.828▲ |
STOCH | 25.000 | 22.738 | 14.932▼ | 59.069 | 48.065 |
WILL %R | -33.333 | -80.488▼ | -80.952▼ | -59.722 | -43.434 |
CCI | 21.212 | -104.252▼ | -105.615▼ | 50.623 | 197.978▲ |
Thursday, October 09, 2025 04:10 AM
Event to be held October 14th at 4 p.m. ESTBETHESDA, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company ...
|
Monday, October 06, 2025 05:29 AM
Improvement observed in MDS-UPDRS scores in first 9 participants enrolled; 90-day follow-up continuing in remaining participants Plasma exposures in patients within projected therapeutic range and ...
|
Monday, September 22, 2025 05:00 PM
BETHESDA, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
10/10/25 | 2.12 | 2.13 | 1.92 | 1.97 | 1,128,423 |
09/10/25 | 2.04 | 2.15 | 2.025 | 2.08 | 901,140 |
08/10/25 | 2.10 | 2.20 | 2.00 | 2.07 | 907,930 |
07/10/25 | 2.29 | 2.35 | 1.929 | 2.02 | 2,269,929 |
06/10/25 | 1.94 | 2.40 | 1.9204 | 2.22 | 3,027,408 |
03/10/25 | 1.87 | 1.9296 | 1.80 | 1.92 | 644,971 |
02/10/25 | 1.83 | 1.94 | 1.80 | 1.86 | 711,858 |
01/10/25 | 1.77 | 1.8663 | 1.75 | 1.82 | 411,531 |
30/09/25 | 1.81 | 1.93 | 1.74 | 1.77 | 924,369 |
29/09/25 | 1.82 | 1.88 | 1.78 | 1.81 | 595,995 |
|
|
||||
|
|
||||
|
|